LABD ETF

LABD ETF
$8.22
See how much of LABD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-0.87%
3 Months
-24.42%
6 Months
-51.90%
YTD
-66.49%
1 Year
-74.20%
3 Years (annualized)
-69.24%
5 Years (annualized)
-48.03%
10 Years (annualized)
-58.59%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would LABD have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
S&P Biotechnology Select Industry Index(^SPSIBI:SP)
This ETF (YTD)
-66.49%
Peer Avg (YTD)
+1.93%
vs Peers
-68.41%

LABD ETF Performance

LABD performance across multiple time periods: 1-month -0.87%, YTD -66.49%, 1-year -74.20%, 3-year -69.24%, 5-year -48.03%, 10-year -58.59%.

LABD returns trail the peer average of 1.93% YTD. With an expense ratio of 1.07%, investors should weigh costs against performance when evaluating this ETF.

LABD vs another fund shows side-by-side returns. LABD alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal Return
1 Month-0.87%
3 Months-24.42%
6 Months-51.90%
1 Year-74.20%
3 Years-69.24%
5 Years-48.03%

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized. Return figures last updated Nov 15, 2026.